CRISPR Therapeutics Appoints James R. Kasinger as General Counsel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. HD
6. DVLT
7. LOW
8. MRK
9. PGR
10. EPM

Go back to CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
(NASDAQ: CRSP) Delayed: 59.03 +6.06 (11.44%)
Previous Close $52.97    52 Week High $18.88 
Open $55.00    52 Week Low $13.75 
Day High $59.05    P/E N/A 
Day Low $54.99    EPS $0.00 
Volume 2,230,550